A new study from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, suggests positron emission tomography (PET) brain scans could reveal hidden inflammation ...

SHREVEPORT, La. - The Center for Molecular Imaging and Therapy, a subsidiary of BRF, proudly announces its new collaboration with the Brain Health Alliance as an imaging site in the nationwide EPSMS ...

Five out of six patients in FDA authorized Expanded Access Program are showing a qualitative reduction in microglia activation (a key biomarker being observed) Foralumab to advance into Phase 2 human ...

Research at Bristol Myers Squibb Co. has led to the development of [11]-carbon-labeled compounds targeting Bruton tyrosine kinase (BTK) as positron emission tomography (PET) imaging agents for the ...

Artificial intelligence (AI), using a simple blood test combined with standard brain images has, for the first time, been ...

TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (QNTM) (FRA: 0K91) “Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative ...

Quantum Biopharma expects data from two now-completed, FDA-requested toxicology studies to support clinical testing of its ...

ETH Zurich researchers have developed a new method of magnetic resonance imaging (MRI) for the early detection and better monitoring of multiple sclerosis (MS). The method maps the myelin sheaths in ...

By analysing MRI scans and a simple blood test from hundreds of patients, researchers identified patterns that reveal how ...

A recent Npj Digital Medicine study assesses the accuracy and effectiveness of artificial intelligence (AI)-based imaging techniques to diagnose multiple sclerosis (MS). Study: A real-world clinical ...

"In terms of association with climate, our results suggest a relationship between enhancing lesions and tropical nights, a variable indicating extreme temperatures, which had not been previously ...